New brazilian COVID booster enters human testing
NCT ID NCT07134725
Summary
This study tested a new COVID-19 booster vaccine called SpiN-Tec. It involved 432 healthy adults who were already fully vaccinated against COVID-19. The goal was to check if the new booster was safe and could trigger a strong immune response, comparing it to an already approved booster shot.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculdade de Medicina da UFMG - Unidade de Pesquisa Clínica em Vacinas (UPqVac)
Belo Horizonte, Minas Gerais, 30130-100, Brazil
Conditions
Explore the condition pages connected to this study.